{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal Stempeucel",
            "NStudiesAvail": 430108,
            "NStudiesFound": 2,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 2,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "This is an open label, non-randomized, dose ranging study to evaluate the safety and efficacy of different doses of Stempeucel in critical limb ischemia patients."
                        ],
                        "BriefTitle": [
                              "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "March 2016"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Critical Limb Ischemia",
                              "Buerger's Disease"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000001157",
                              "D000014652",
                              "D000002318",
                              "D000014657"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Arterial Occlusive Diseases",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Vasculitis"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC23",
                              "All",
                              "BC14",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT01484574"
                        ]
                  },
                  {
                        "Rank": 2,
                        "BriefSummary": [
                              "This study is being conducted as an extension of the phase II clinical trial SRPL/CLI/10-11/001 (NCT01484574). The CDSCO has recommended flexibility for continued clinical study in consultation with ICMR, as per recommendation of Cellular biology based therapeutic drug evaluation committee (CBBTDEC)."
                        ],
                        "BriefTitle": [
                              "A Clinical Trial to Study the Efficacy and Safety of Stempeucel\u00ae in Patients With CLI Due to Buergers Disease"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "October 2019"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Critical Limb Ischemia Due to Buerger's Disease"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000001157",
                              "D000014652",
                              "D000002318",
                              "D000014657"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Arterial Occlusive Diseases",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Vasculitis"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC23",
                              "All",
                              "BC14",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT03056742"
                        ]
                  }
            ]
      }
}